Referral & Payor Leverage Index™

Independent skilled home health agencies are operating in a structurally different environment than five years ago. Medicare Advantage penetration, centralized discharge planning, and data-driven panel decisions have increased concentration exposure for agencies dependent on a limited number of referral and payor channels.

This Snapshot is designed to be completed privately by the skilled home care agency owner or administrator. There are no right answers. It works best when you answer conservatively. If you’re unsure whether something would hold up consistently with referral sources or payors, mark “No.” All questions are required. Responses are stored locally in your browser.

Dimension 1. External Differentiation Defensibility

This dimension assesses whether referral partners and payors would describe your agency distinctly without your involvement. If differentiation is not externally understood, preference can drift toward convenience, habit, or whoever is most visible.

Dimension 1, Q1: If a referral partner were asked what differentiates your agency, would they give a specific, consistent answer without prompting?
Dimension 1, Q2: Can you and your partner-facing team members clearly explain who you are best suited to serve and who you are not, without hedging?
Dimension 1, Q3: Do your website and materials reflect the same positioning you use in conversations?
Dimension 1, Q4: If a new referral source reviewed your materials alone, would they understand why to choose you over alternatives?

Dimension 2. Portable Proof and Scrutiny Readiness

This dimension assesses whether your strengths are verifiable and portable, not just believed internally. When volume tightens or scrutiny increases, undocumented strength becomes harder to defend.

Dimension 2, Q1: Do you have specific proof points you and your partner-facing team members routinely reference when credibility is tested (examples, outcomes, cases, or patterns)?
Dimension 2, Q2: Would an outside reviewer see evidence of reliability and follow-through, not just good intent?
Dimension 2, Q3: Are your strengths documented in a way that travels without you being present?
Dimension 2, Q4: If challenged on quality or consistency, could you and your partner-facing team members respond with facts, not assurances?

Dimension 3. Referral Concentration Risk

This dimension evaluates exposure to referral concentration and invisible preference shifts. High dependence often feels stable until it isn’t. The risk is not losing a source suddenly. The risk is not seeing preference decay until it impacts operations.

Threshold anchors:
If your top 2 referral sources exceed 40% of total revenue, a change in behavior from one decision-maker could noticeably reduce annual revenue.
If your top 3 exceed 55%, your revenue depends heavily on a small cluster of people or institutions.

Dimension 3, Q1: Could you afford to lose your largest referral source without immediate operational distress?
Dimension 3, Q2: Do you understand why your top referral sources choose you, beyond convenience or history?
Dimension 3, Q3: Are you actively strengthening referral source relationships before volume changes, not after?
Dimension 3, Q4: If referral behavior shifted quietly, would you see only after impact?
Dimension 3, Q5 (Quantitative): What percent of total revenue comes from your top 2 referral sources?
Dimension 3, Q6 (Quantitative): What percent of total revenue comes from your top 3 referral sources?

Dimension 4. Payor Concentration Risk

This dimension evaluates exposure to payor leverage and reimbursement volatility.

Threshold anchors:
If one Medicare Advantage plan exceeds 35–40% of revenue, rate adjustments or authorization friction can materially affect margin and cash flow.
If 50%+ revenue is MA-driven without differentiated contracts, small reimbursement changes can compound quickly.

Dimension 4, Q1 (Quantitative): What percent of revenue is tied to your largest Medicare Advantage plan?
Dimension 4, Q2: Do you have differentiated contract terms or leverage with your largest MA plan?
Dimension 4, Q3: Would a rate adjustment materially impact EBITDA?
Dimension 4, Q4: Are you actively managing payor mix rather than accepting drift?
Dimension 4, Q5: Do you have a repeatable process for monitoring MA friction (authorizations, denials, delays) before it hits cash flow?

Dimension 5: Operational Signaling

This dimension looks at whether your operations send a positive signal externally, not just internally. Referral partners and payors notice friction, inconsistency, and how breakdowns are handled.

Dimension 5, Q1: Would referral partners describe your agency as easy to work with, even under pressure?
Dimension 5, Q2: Are your internal processes stable enough that growth would not degrade performance?
Dimension 5, Q3: If asked how your agency handles breakdowns, could you and your partner-facing team members explain a clear, repeatable approach?
Dimension 5, Q4: Would an external reviewer conclude your agency is prepared for increased scrutiny, not just current volume?